HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
8 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
MS4A10
membrane spanning 4-domains A10
Chromosome 11 · 11q12.2
NCBI Gene: 341116Ensembl: ENSG00000172689.2HGNC: HGNC:13368UniProt: Q96PG2
9PubMed Papers
7Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Receptor
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingcell surface receptor signaling pathwayplasma membranemembranevitamin B deficiencyCrohn's diseasegastric cancerulcerative colitis
✦AI Summary

MS4A10 is a membrane-spanning protein belonging to the MS4A (membrane-spanning 4-domains A) gene family, clustered on chromosome 11 1. As a structural homologue of CD20 and the IgE receptor beta chain, MS4A10 contains four transmembrane domains with cytoplasmic N- and C-terminal domains, positioning it as a likely component of oligomeric cell surface receptor complexes involved in signal transduction 1. Unlike other MS4A family members with broad tissue expression, MS4A10 transcripts are rare and show restricted expression patterns, not detected in most hematopoietic cells or nonlymphoid tissues 1. In gastric cancer models, MS4A10 protein levels were significantly decreased following treatment with traditional Chinese medicine (SFA and matrine) combined with 5-fluorouracil, correlating with enhanced apoptosis and reduced cell proliferation 2. This downregulation of MS4A10 was associated with decreased expression of anti-apoptotic proteins and increased pro-apoptotic markers, suggesting MS4A10 may promote cell survival or proliferation in cancer contexts 2. While MS4A10 expression has been examined in cancer biology, its specific signaling mechanisms and physiological functions in normal tissues remain incompletely characterized.

Sources cited
1
MS4A10 is a member of the MS4A gene family located on chromosome 11q12, contains four transmembrane domains with cytoplasmic termini, is likely a component of oligomeric cell surface signal transduction complexes, and shows rare transcripts not detected in most hematopoietic cells and nonlymphoid tissues
PMID: 11486273
2
MS4A10 protein expression is decreased in gastric cancer cells treated with SFA/matrine combined with 5-FU, correlating with reduced proliferation and enhanced apoptosis
PMID: 36438804
⚠Limited data available — This gene has 2 indexed publications. Summary and analysis may be incomplete.
Disease Associationsⓘ7
vitamin B deficiencyOpen Targets
0.29Weak
Crohn's diseaseOpen Targets
0.06Suggestive
gastric cancerOpen Targets
0.02Suggestive
ulcerative colitisOpen Targets
0.02Suggestive
colorectal cancerOpen Targets
0.02Suggestive
neoplasmOpen Targets
0.01Suggestive
ovarian serous cystadenocarcinomaOpen Targets
0.00Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
CD101Shared pathway100%ADGRL1Shared pathway100%CLEC1AShared pathway100%MS4A7Shared pathway100%ADGRL4Shared pathway100%MS4A5Shared pathway100%
Tissue Expression6 tissues
Ovary
100%
Liver
87%
Lung
87%
Brain
30%
Bone Marrow
0%
Heart
0%
Gene Interaction Network
Click a node to explore
MS4A10CD101ADGRL1CLEC1AMS4A7ADGRL4MS4A5
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q96PG2
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.44LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF1.01 [0.72–1.44]
RankingsWhere MS4A10 stands among ~20K protein-coding genes
  • #17,379of 20,598
    Most Researched9
  • #14,752of 17,882
    Most Constrained (LOEUF)1.44
Genes detectedMS4A10
Sources retrieved8 papers
Response time—
📄 Sources
8▼
1
Structural organization of the human MS4A gene cluster on Chromosome 11q12.
PMID: 11486273
Immunogenetics · 2001
1.00
2
Effects of
PMID: 36438804
Front Pharmacol · 2022
0.88
3
CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer.
PMID: 32797167
Biosci Rep · 2020
0.75
4
Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.
PMID: 27881006
Neoplasma · 2017
0.63
5
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer.
PMID: 33542444
Pharmacogenomics J · 2021
0.50